More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

Appendix 4E & Annual Report to 30 June 2024

Aug 27, 2024 at 10:27 PM EDT · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Aug 27, 2024 at 10:27 PM EDT · 55 pages · English

On 6ix: 6ix.com/news/appendix-4e-and-annual-report-to-30-june-2024

EMvision Medical Devices Ltd. on 6ix

Story so far

  • Encouraging Interim Clinical Trial ResultsOct 10, 2023
  • Appendix 4E & Annual Report to 30 June 2023Aug 30, 2023
  • Appendix 4E & Annual Report to 30 June 2022Aug 30, 2022

Earlier from EMvision Medical Devices

  • First Responder Device UnveiledJul 22, 2024
  • Stage 3 Recuitment Achieved & FDA Engagement UnderwayJul 7, 2024
  • Pilot Production Line Established & $1.25m Grant ReceivedJun 23, 2024
  • Trial data confirms early ischaemia detection capabilitiesMay 26, 2024
  • Stage 2 Insights Confirm Diagnostic & Clinical ViabilityMar 26, 2024

Later from EMvision Medical Devices

  • EMV Prepares for Trial Following Positive FDA EngagementOct 28, 2024
  • Algorithms Deliver Excellent Results In EMView StudyNov 11, 2024
  • EMVision Receives $2.12m R&D Tax RebateJan 19, 2025
  • US Ethics Approval Received for Pivotal Validation TrialFeb 11, 2025
  • EMVision Releases its FY25 Half Yearly ReportFeb 27, 2025
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer